204 related articles for article (PubMed ID: 21312191)
1. Interferon-α induces unabated production of short-lived plasma cells in pre-autoimmune lupus-prone (NZB×NZW)F1 mice but not in BALB/c mice.
Mathian A; Gallegos M; Pascual V; Banchereau J; Koutouzov S
Eur J Immunol; 2011 Mar; 41(3):863-72. PubMed ID: 21312191
[TBL] [Abstract][Full Text] [Related]
2. Plasma cells in systemic lupus erythematosus: the long and short of it all.
Liu Z; Zou Y; Davidson A
Eur J Immunol; 2011 Mar; 41(3):588-91. PubMed ID: 21341259
[TBL] [Abstract][Full Text] [Related]
3. High frequency of autoantibody-secreting cells and long-lived plasma cells within inflamed kidneys of NZB/W F1 lupus mice.
Starke C; Frey S; Wellmann U; Urbonaviciute V; Herrmann M; Amann K; Schett G; Winkler T; Voll RE
Eur J Immunol; 2011 Jul; 41(7):2107-12. PubMed ID: 21484784
[TBL] [Abstract][Full Text] [Related]
4. IFN-α confers resistance of systemic lupus erythematosus nephritis to therapy in NZB/W F1 mice.
Liu Z; Bethunaickan R; Huang W; Ramanujam M; Madaio MP; Davidson A
J Immunol; 2011 Aug; 187(3):1506-13. PubMed ID: 21705616
[TBL] [Abstract][Full Text] [Related]
5. Bone marrow of NZB/W mice is the major site for plasma cells resistant to dexamethasone and cyclophosphamide: implications for the treatment of autoimmunity.
Mumtaz IM; Hoyer BF; Panne D; Moser K; Winter O; Cheng QY; Yoshida T; Burmester GR; Radbruch A; Manz RA; Hiepe F
J Autoimmun; 2012 Sep; 39(3):180-8. PubMed ID: 22727274
[TBL] [Abstract][Full Text] [Related]
6. Soluble human CD83 ameliorates lupus in NZB/W F1 mice.
Starke C; Steinkasserer A; Voll RE; Zinser E
Immunobiology; 2013 Nov; 218(11):1411-5. PubMed ID: 23886695
[TBL] [Abstract][Full Text] [Related]
7. Role of microRNA-15a in autoantibody production in interferon-augmented murine model of lupus.
Yuan Y; Kasar S; Underbayev C; Vollenweider D; Salerno E; Kotenko SV; Raveche E
Mol Immunol; 2012 Sep; 52(2):61-70. PubMed ID: 22578383
[TBL] [Abstract][Full Text] [Related]
8. Autoantibodies from long-lived 'memory' plasma cells of NZB/W mice drive immune complex nephritis.
Cheng Q; Mumtaz IM; Khodadadi L; Radbruch A; Hoyer BF; Hiepe F
Ann Rheum Dis; 2013 Dec; 72(12):2011-7. PubMed ID: 24114925
[TBL] [Abstract][Full Text] [Related]
9. Genomic view of IFN-alpha response in pre-autoimmune NZB/W and MRL/lpr mice.
Lu Q; Shen N; Li XM; Chen SL
Genes Immun; 2007 Oct; 8(7):590-603. PubMed ID: 17728792
[TBL] [Abstract][Full Text] [Related]
10. Allogeneic mesenchymal stem cells do not protect NZBxNZW F1 mice from developing lupus disease.
Youd M; Blickarz C; Woodworth L; Touzjian T; Edling A; Tedstone J; Ruzek M; Tubo R; Kaplan J; Lodie T
Clin Exp Immunol; 2010 Jul; 161(1):176-86. PubMed ID: 20456409
[TBL] [Abstract][Full Text] [Related]
11. T cell cytokine imbalance towards production of IFN-gamma and IL-10 in NZB/W F1 lupus-prone mice is associated with autoantibody levels and nephritis.
Enghard P; Langnickel D; Riemekasten G
Scand J Rheumatol; 2006; 35(3):209-16. PubMed ID: 16766368
[TBL] [Abstract][Full Text] [Related]
12. Intrinsic defects in macrophage IL-12 production associated with immune dysfunction in the MRL/++ and New Zealand Black/White F1 lupus-prone mice and the Leishmania major-susceptible BALB/c strain.
Alleva DG; Kaser SB; Beller DI
J Immunol; 1998 Dec; 161(12):6878-84. PubMed ID: 9862720
[TBL] [Abstract][Full Text] [Related]
13. Long-term B cell depletion in murine lupus eliminates autoantibody-secreting cells and is associated with alterations in the kidney plasma cell niche.
Wang W; Rangel-Moreno J; Owen T; Barnard J; Nevarez S; Ichikawa HT; Anolik JH
J Immunol; 2014 Apr; 192(7):3011-20. PubMed ID: 24574498
[TBL] [Abstract][Full Text] [Related]
14. Cyclophosphamide treatment for hypertension and renal injury in an experimental model of systemic lupus erythematosus.
Wolf VL; Taylor EB; Ryan MJ
Physiol Rep; 2019 May; 7(10):e14059. PubMed ID: 31124322
[TBL] [Abstract][Full Text] [Related]
15. IgG1 and IgG2a production by autoimmune B cells treated in vitro with IL-4 and IFN-gamma.
Klinman DM
J Immunol; 1990 Apr; 144(7):2529-34. PubMed ID: 2108205
[TBL] [Abstract][Full Text] [Related]
16. Interferon-α accelerates murine systemic lupus erythematosus in a T cell-dependent manner.
Liu Z; Bethunaickan R; Huang W; Lodhi U; Solano I; Madaio MP; Davidson A
Arthritis Rheum; 2011 Jan; 63(1):219-29. PubMed ID: 20954185
[TBL] [Abstract][Full Text] [Related]
17. Identification of new pathogenic players in lupus: autoantibody-secreting cells are present in nephritic kidneys of (NZBxNZW)F1 mice.
Lacotte S; Dumortier H; Décossas M; Briand JP; Muller S
J Immunol; 2010 Apr; 184(7):3937-45. PubMed ID: 20181885
[TBL] [Abstract][Full Text] [Related]
18. Loss of epigenetic modifications on the inactive X chromosome and sex-biased gene expression profiles in B cells from NZB/W F1 mice with lupus-like disease.
Syrett CM; Sierra I; Beethem ZT; Dubin AH; Anguera MC
J Autoimmun; 2020 Feb; 107():102357. PubMed ID: 31780316
[TBL] [Abstract][Full Text] [Related]
19. Plasmacytoid dendritic cells from parent strains of the NZB/W F1 lupus mouse contribute different characteristics to autoimmune propensity.
Zhan Y; Kong I; Chopin M; Macri C; Zhang JG; Xie J; Nutt SL; O'Keeffe M; Hawkins ED; Morand EF; Lew AM
Immunol Cell Biol; 2020 Mar; 98(3):203-214. PubMed ID: 31916630
[TBL] [Abstract][Full Text] [Related]
20. A novel function of B lymphocytes from normal mice to suppress autoimmunity in (NZB x NZW)F1 mice.
Ono S; Shao D; Yamada S; Yang Y; Yamashita M; Hamaoka T
Immunology; 2000 May; 100(1):99-109. PubMed ID: 10809965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
